What the business is, and whether it's a good one at a fair price.
Provides AI-embedded commercial and medical outsourcing services to global life sciences companies, particularly large pharmaceutical firms. Enterprise Commercial Solutions, which contributed 70.1% of segment revenue at ₹2,460.5 crore in FY26, handles sales, marketing and omnichannel engagement work for pharma clients. Enterprise Medical Solutions, contributing 26.5% at ₹929.8 crore, covers medical affairs, scientific content and clinical communications. The company serves 20 of the Top 20 global pharma companies and 80 of the Top 100 life sciences firms, with an active client base that grew from 73 to 91 in FY26 and reached 105 by Q1 FY27. Employee costs are the dominant input at 62.6% of revenue, reflecting a delivery model built on specialised healthcare and technology talent rather than physical inputs. The company reports 98.47% export revenue, operates across 58 countries and runs 5,167 employees, with revenue per employee at approximately $77,000.
Measured from the filed financials, judged against its Healthcare Services peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from INDEGENE LIMITED's filed financials and exchange disclosures
INDEGENE LIMITED is a Healthcare Services company listed on NSE and BSE, trading under the symbol INDGN.
Yes. Over the trailing twelve months INDEGENE LIMITED reported a net profit of ₹401 Cr on revenue of ₹3,813 Cr.
Yes. The dividend yield is 0.34% at the current price. It paid out 12% of its profit as dividend in FY26.
Effectively yes. It holds ₹301 Cr more cash than debt. Debt stands at 0.00× equity.
On trailing P/E, INDEGENE LIMITED ranks 37 of 68 in Healthcare Services — cheaper than 46% of them, against an industry median of 31.2×. This is a position, not a valuation judgement.
On a typical session INDEGENE LIMITED moves 0.92% — that is the median absolute close-to-close move across its last 269 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by INDEGENE LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
